PT  - JOURNAL ARTICLE
AU  - Correira, John W.
AU  - Kamstra, Rhiannon
AU  - Zhu, Nanqing
AU  - Doll, Margaret K.
TI  - Evaluation of School Vaccine Coverage and Medical Vaccine Exemptions Following the Repeal of School Entry Nonmedical Vaccine Exemption Options in New York State
AID  - 10.1101/2023.08.17.23294227
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.08.17.23294227
4099  - http://medrxiv.org/content/early/2023/08/23/2023.08.17.23294227.short
4100  - http://medrxiv.org/content/early/2023/08/23/2023.08.17.23294227.full
AB  - Importance Following the repeal of nonmedical vaccine exemption options from school entry immunization laws in California, gains in vaccine coverage were partially offset by increases in medical vaccine exemptions. Although several U.S. states, including New York State (NYS), recently adopted similar legislation, the impact of these laws on school vaccine coverage and medical vaccine exemptions has not yet been examined.Objective To estimate the effects of NYS legislation eliminating nonmedical school entry vaccine exemptions on required vaccine coverage and the uptake of medical vaccine exemptions at NYS schools outside of New York City (NYC).Design Interrupted time-series analyses using generalized estimating equations to examine longitudinal school immunization compliance data from the 2012-13 through 2021-22 school years.Setting New York State public and nonpublic schools outside of NYC.Participants Schools that submitted ≥1 compliance report in the time periods before and after the legislative repeal of nonmedical exemptions with publicly available student enrollment data.Exposure NYS Senate Bill 2994A was passed in June 2019, eliminating school entry nonmedical vaccine exemptions; since compliance with the law was evaluated for most students during the following school year, we considered the 2019-20 school year as the law’s effective date.Main Outcomes and Measures Main outcomes examined were school required vaccine coverage, defined as the percentage of students at each school who completed all grade-appropriate NYS vaccine requirements, and the percentage of students with a medical vaccine exemption.Results Among 3,525 eligible schools, the implementation of NYS Senate Bill 2994A was associated with an increase in mean required vaccine coverage of 5% and 1% among nonpublic and public schools, respectively, with additional annual increases in coverage observed through the 2021-22 school year. The law’s implementation was also associated with a 0.1% (95% CI: 0.0%, 0.1%) decrease in medical vaccine exemptions at both public and nonpublic schools, and small, but significant mean annual declines in medical vaccine exemptions through the end of the study period.Conclusion and Relevance The NYS elimination of school entry nonmedical vaccine exemption options was effective to improve required vaccine coverage; coverage gains were not replaced by increases in medical vaccine exemptions.Question Was the New York State (NYS) law eliminating nonmedical vaccine exemption options from school entry vaccine requirements effective to increase vaccine coverage among NYS schools (outside of New York City)?Findings Using interrupted time-series analyses, we found the implementation of the NYS law was associated with an increase in mean required vaccine coverage at NYS schools; small, but significant declines in medical exemptions were also observed in relation to the law.Meaning State legislation eliminating nonmedical vaccine exemption options from school entry vaccine laws can be effective to improve school vaccine coverage without replacement by medical vaccine exemptions.Competing Interest StatementMKD has received a U.S. National Institute of Health subaward and St. Luke's Wood River Community Grant funds for unrelated research. RK and NZ are employed by Precision Analytics, Inc., a consultancy that receives research grants and consulting fees from other clients and entities for unrelated work. The other authors have stated they do not have any conflicts of interest to declare.Funding StatementThis work was supported by a new faculty start-up award from the Albany College of Pharmacy and Health Sciences. No other sources of funding were secured for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data used in these analyses are publicly available from the New York State Department of Health and the New York State Education Department.